Hologic announced today that it named a seasoned medtech veteran as its CEO after closing its go-private acquisition.

MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas, April 07, 2026--Blackstone and TPG Complete Acquisition of ...

The company appointed Almeida as chief executive in conjunction with the completion of an $18.3 billion go-private deal.

Hologic Inc. shares hit a fresh 52-week high of $76.07 Tuesday as the medical technology company's $18.3 billion buyout by ...

Hologic (Nasdaq:HOLX) announced today that CEO Steve MacMillan intends to retire following the closing of its pending ...

Private equity firms Blackstone and TPG completed their buyout of the Marlborough medical device maker this week.

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

Marlborough medical device manufacturer Hologic is anticipating to make an unspecified number of layoffs at international locations this year amid a restructuring of its diagnostics division, as sales ...

In replacing Hologic, the index committee at S&P Dow Jones opted for a convenience-store retailer instead of another ...

Hologic President and CEO Steve MacMillan is stepping down after nearly 13 years, marking the end of an era for the medtech company. | Hologic President and CEO Steve MacMillan is stepping down after ...

Hologic’s recall of its BioZorb Markers due to complications with the implanted device were recently identified as Class I by FDA after 71 injuries were reported as being related to BioZorb Markers.

Hologic, Inc. (Nasdaq: HOLX) announced today that Steve MacMillan, its long-time Chairman, President and Chief Executive Officer (CEO), has decided to retire when the Company’s go-private transaction ...